|
| Press Releases |
|
 |
|
| Tuesday, June 7, 2022 |
|
|
Novotech助力Endpoints ASCO 2022年專家組，加速中國腫瘤臨床試驗 |
| Novotech是亞太地區領先的生物技術臨床研究機構，近期入駐美國，助力Endpoints ASCO 2022年專家組，加速中國和美國臨床試驗進程。 more info >> |
|
|
Novotech助力Endpoints ASCO 2022年专家组，加速中国肿瘤临床试验 |
| Novotech是亚太地区领先的生物技术临床研究机构，近期入驻美国，助力Endpoints ASCO 2022年专家组，加速中国和美国临床试验进程。 more info >> |
|
| Monday, June 6, 2022 |
|
|
Novotech Sponsors Endpoints ASCO 2022 Expert Panel on Accelerating Oncology Clinical Trials in China |
| Novotech, the leading Asia Pacific biotech specialist CRO which has recently expanded its services to the US, is sponsoring the Endpoints ASCO 22 "Accelerating clinical development in China and the US". more info >> |
|
| Friday, June 3, 2022 |
|
|
노보텍, 초기 단계 종양학 임상 및 미-중 규제 전략에 관한 프리-ASCO 중국 서밋의 전문가 패널들을 후원 |
| 최근 미국으로 서비스를 확장한 바 있는 아시아 태평양 지역 바이오테크 전문 임상 시험수탁기관(CRO)인 노보텍(Novotech)은 중국과 미국의 종양학 약물 전문가가 참여하는 2022년 프리-ASCO 중국 서밋의 전문가 패널들을 후원했다. more info >> |
|
|
Novotech 贊助 ASCO 中國峰會前中美早期腫瘤試驗和監管策略專家組 |
| Novotech 是亞太地區領先的生物技術專家 CRO，最近將其服務擴展到美國，在 2022 年 ASCO 前中國峰會上贊助了專家小組，匯集了中國和美國腫瘤藥物開發的領導者。 Pre-ASCO 系列在全球有超過 20,000 人觀看。 more info >> |
|
|
Novotech 赞助 ASCO 中国峰会前中美早期肿瘤试验和监管策略专家组 |
| Novotech 是亚太地区领先的生物技术专家 CRO，最近将其服务扩展到美国，在 2022 年 ASCO 前中国峰会上赞助了专家小组，汇集了中国和美国肿瘤药物开发的领导者。 more info >> |
|
| Thursday, June 2, 2022 |
|
|
Novotech Sponsors Pre-ASCO China Summit Panels on Early Phase Oncology Trials, Regulatory Strategy for China and US |
| Novotech, the leading Asia Pacific biotech specialist CRO with recently expanded services to the US, sponsored expert panels at the Pre-ASCO China Summit 2022, bringing together leaders in oncology drug development in China and the US. more info >> |
|
| Thursday, May 12, 2022 |
|
|
노보텍, 프리-ASCO중국 서밋 후원: 초기 단계 종양학 임상에 기반해 진행 여부 결정 |
| 최근 미국으로 서비스를 확장한 바 있는 아시아 태평양 지역 바이오테크 전문 임상시험수탁기관(CRO)인 노보텍(Novotech)은 '초기 단계 종양학 임상에 기반해 진행 여부 결정'이라는 제목의 2022년 프리-ASCO 중국 서밋(이하 '서밋')을 후원하게 된다. more info >> |
|
|
Novotech 贊助 ASCO 中國峰會前夕：基於早期腫瘤學試驗的 Go/No Go 決策 |
| Novotech 是亞太地區領先的生物技術專家 CRO，最近將其 CRO 服務擴展到美國，很高興贊助 2022 年 ASCO 中國峰會前活動，題為：基於早期腫瘤試驗的 Go/No Go Decisions（“峰會”）。 more info >> |
|
|
Novotech 赞助 ASCO 中国峰会前夕：基于早期肿瘤学试验的 Go/No Go 决策 |
| Novotech 是亚太地区领先的生物技术专家 CRO，最近将其 CRO 服务扩展到美国，很高兴赞助 2022 年 ASCO 中国峰会前活动，题为：基于早期肿瘤试验的 Go/No Go Decisions（“峰会”）。 more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
富士通、海上自衛隊様の全物資情報をリアルタイムで管理する基幹業務システムを提供
May 26, 2026 13:35: JST
|
|
|
Six Factors to Consider When Opting for a Credit Line in Singapore
May 26, 2026 12:45 HKT/SGT
|
|
|
Sentire(R) Surgical System Receives EU CE Mark (MDR) and Singapore HSA Approval, Cornerstone Robotics Accelerates Global Strategic Expansion
May 26, 2026 12:28 HKT/SGT
|
|
|
Sentire思騰(R)腔鏡手術機械人獲歐盟CE與新加坡HSA雙認證, 康諾思騰（Cornerstone Robotics）全球化戰略全面提速
May 26, 2026 12:28 HKT/SGT
|
|
|
富士通、スーパーコンピュータ「京」や「富岳」の高速化にも寄与した演算処理技術に関する発明が、全国発明表彰にて「内閣総理大臣賞」を受賞
May 26, 2026 11:30: JST
|
|
|
三菱 UFJ 信託銀行とエーザイ、認知機能に関する情報提供を通じた高齢者向け金融サービスの強化に向けて連携
May 26, 2026 09:05: JST
|
|
|
宇樹科技IPO上會在即 首程控股（697.HK）機器人資產迎估值重估
May 26, 2026 08:44 HKT/SGT
|
|
|
Unitree Robotics IPO Review Approaches, Shoucheng Holdings Robot Assets Poised for Valuation Re-rating
May 26, 2026 08:35 HKT/SGT
|
|
|
Patents Build Solid Barriers, Technologies Achieve All-Round Breakthroughs, New Vision Leads the New Track of AR Interaction
May 25, 2026 22:24 HKT/SGT
|
|
|
How to Manage Large Purchases During Sale Season Responsibly
May 25, 2026 14:00 HKT/SGT
|
|
|
Successful Demonstration of Stable, High-Capacity mmWave Communications for Multiple High-Speed Vehicles for the 6G Era
May 25, 2026 14:58 JST
|
|
|
富士通、業務とともに学び続ける自己進化マルチAIエージェント技術を開発
May 25, 2026 13:30: JST
|
|
|
Fujitsu develops self-evolving multi-AI agent technology that learns and adapts to business operations
May 25, 2026 14:13 JST
|
|
|
Sentire(R) Surgical System Receives CE Mark (MDR) and Singapore HSA Dual Certification, Cornerstone Robotics Enters a New Era in its Global Expansion
May 25, 2026 12:14 HKT/SGT
|
|
|
「マツダ」と「スピングル」のコラボスニーカーを発売
May 25, 2026 11:50: JST
|
|
|
|
|
More News >> |
|
|
|
|
|
